CDH1 and ovarian cancer: Studies on ovarian cancer have shown that the downregulation of Galectin-1 with siRNA-based strategies increases the mRNA levels of E-cadherin and decreases the levels of N-cadherin, MMP7, fibronectin, Snail, and Slug, thereby inhibiting the EMT pathway [61].